The Delhi High Court has passed an ex parte injunction in favour of Smithkline Beecham, restraining a Haryana-based firm from selling pharmaceutical preparations under the trade mark, Procin, which is deceptively similar to the trade mark, Crocin.
Top Section
Explore Business Standard
Don’t miss the latest developments in business and finance.
The Delhi High Court has passed an ex parte injunction in favour of Smithkline Beecham, restraining a Haryana-based firm from selling pharmaceutical preparations under the trade mark, Procin, which is deceptively similar to the trade mark, Crocin.
First Published: Jan 14 2002 | 12:00 AM IST